Welcome to our dedicated page for National Resh news (Ticker: NRC), a resource for investors and traders seeking the latest updates and insights on National Resh stock.
NRC Health reports developments in healthcare experience improvement solutions for hospitals and health systems. Its updates cover products and services such as Patient Experience, Market Insights, Reputation, Leader Rounding, and The Governance Institute, a service that provides governance research, education, assessments, conferences, and advisory resources for not-for-profit hospital and health system boards.
Company news commonly includes quarterly operating results, Total Recurring Contract Value disclosures tied to renewable contracts, cash flow and adjusted performance measures, health system partnership expansions, online reputation and consumer insight initiatives, industry recognition, governance publications, and capital allocation actions such as share repurchase authorizations.
NRC Health (NASDAQ:NRC) released new nSight research, “The Currency of Time: Easy Access to Care Isn’t Enough to Earn Patient Loyalty,” showing that confidence, trust, and clear communication have a stronger association with patient loyalty than access speed alone.
The analysis combines nationally syndicated consumer research with feedback from tens of millions of patients across hundreds of organizations. Findings include loyalty dropping from 98% with no friction to 58% when issues occur before, during, and after care, and that 59% of older consumers reported no access barriers versus 37% of Gen Z and Millennials. NRC Health will host a national webcast on August 18 to discuss the results.
NRC Health (NASDAQ: NRC) reported second quarter 2026 results with Total Recurring Contract Value (TRCV) of $151.9 million, up 11% year-over-year, and revenue of $35.4 million, an increase of 4% from the prior-year quarter.
The company reported a GAAP net loss of $3.3 million (–9% margin), or ($0.15) per diluted share, compared with a net loss of $0.1 million a year earlier. Adjusted net income was $6.9 million (19% of revenue), and Adjusted EBITDA was $9.4 million (27% margin). Operating cash flow totaled $1.4 million, with Free cash flow of $0.1 million, reflecting approximately $2.9 million of cash payments tied to accelerated stock vesting and bonuses. On July 15, 2026, the board declared a quarterly cash dividend of $0.16 per share, payable October 9, 2026, to shareholders of record on September 25, 2026.
NRC Health (NASDAQ:NRC) announced a strategic partnership with the Healthcare Experience Foundation (HXF) to expand support for healthcare organizations seeking to improve patient experience, safety, and workforce engagement.
The collaboration combines NRC Health’s analytics and experience platform with HXF’s leadership and coaching programs, targeting areas such as enterprise alignment, care transitions, leadership rounding, safety culture, and clinician engagement. According to NRC Health, effective leadership rounding is associated with a 15–20-point increase in patient loyalty, while structured care transition programs have helped drive more than 30% improvement in readmission outcomes.
NRC (Nasdaq:NRC) announced that The Governance Institute has formed a Blue Ribbon Committee on Health System Governance. This multidisciplinary group of board leaders, clinicians, academics, advisors, and capital markets experts will convene in summer 2026 to update healthcare governance practices for complex not-for-profit health systems.
The Committee will focus on board design, integrated decision-making, performance expectations at enterprise scale, and improved information flow, and will help translate The Governance Institute’s Governance Trilogy framework into practical tools and board assessment approaches.
NRC Health (NRC) launched new ambient listening and agentic AI capabilities for leader rounding in healthcare settings. The system captures real-time conversations, generating AI summaries that document key topics, actions, and coaching opportunities while leaders stay present with patients and staff.
Early pilots show up to 60X more narrative detail, over 90% of rounds with context-rich documentation, and about 5X more comment data at some sites, supporting stronger analytics, follow-up, and patient experience.
NRC Health (NASDAQ: NRC) reported Q1 2026 results with total revenue $34.8M (up 4% YoY) and TRCV $152.1M (up 13% YoY, sixth consecutive sequential increase). GAAP net income was $3.2M (9% margin); adjusted EBITDA was $9.4M (27% margin). Cash flow from operations was $7.2M (21% of revenue). The board declared a quarterly cash dividend of $0.16 per share, payable July 10, 2026 to holders of record June 26, 2026.
The Governance Institute (service of NRC Health; NYSE:NRC) released Falling Behind on April 27, 2026, arguing health system operations have outpaced governance. The brief cites 1,500 fiduciary boards overseeing ~$900 billion in hospital net patient revenue and finds ~70% of boards lack continuing education.
TGI proposes a three-stage Governance Trilogy™ (Intentional, Integrated, Enterprise) and announced a Blue-Ribbon Committee on Health System Governance to inform reforms.
NRC Health (NRC) announced an expanded partnership with Ann & Robert H. Lurie Children’s Hospital of Chicago to add NRC Health’s Reputation solution to its existing Market Insights and Patient Experience services. The expansion links digital review visibility with consumer insight and patient experience to support trust, access, and choice.
The move aims to unify online reputation, community perception, and patient experience into a single actionable strategy for the hospital.
Piedmont (NRC) named NRC Health as its strategic experience partner on March 19, 2026, to unify experience data and improve care across Piedmont’s system. The partnership targets patient, family, employee, and consumer experience using NRC Health’s Patient Experience, Leader Rounding, and Market Insights solutions and consulting services.
Piedmont serves more than 4.5 million patients annually across 27 hospitals, 115 immediate care locations, and 2,000 locations. The agreement aims to strengthen caregiver engagement, bring the voice of the patient into strategic decisions, and identify system-wide improvement opportunities.
NRC Health (NASDAQ: NRC) announced that its Board authorized a share repurchase program of up to $60 million of outstanding common stock through March 31, 2028. Repurchases may occur in the open market, via privately negotiated transactions, or under Rule 10b5-1 plans and Rule 10b-18 frameworks. The timing, price, and amounts are at the company’s discretion and may be suspended or discontinued.